Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Current Drug Targets|December 15, 2010
Interferon alpha for treatment of chronic myeloid leukemiaBengt Simonsson, Henrik Hjorth-Hansen, Ole Weis Bjerrum, et al.
Case Reports in Gastrointestinal Medicine|March 28, 2013
Symptomatic primary (Al) amyloidosis of the stomach and duodenumReidar Fossmark, Espen Skarsvåg, Harald Aarset, et al.
Journal of Bone and Mineral Metabolism|October 14, 2011
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitroSofia Jönsson, Henrik Hjorth-Hansen, Bob Olsson, et al.
Fertility and Sterility|February 28, 2006
Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulationEszter Vanky, Kjell Asmund Salvesen, Henrik Hjorth-Hansen, et al.
Blood|May 3, 2002
Interleukin-21 is a growth and survival factor for human myeloma cellsAnne-Tove Brenne, Torstein Baade Ro, Anders Waage, et al.
Plos One|January 31, 2017
Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid LeukemiaMohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, et al.
Acta Haematologica|July 31, 2009
Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two casesHege K Vefring, Franz X E Gruber, Line Wee, et al.
Critical Reviews in Oncology/Hematology|December 5, 2017
Ponatinib in chronic myeloid leukemia (CML): Consensus on patient treatment and management from a European expert panelMartin C Müller, Francisco Cervantes, Henrik Hjorth-Hansen, et al.
Haematologica|April 6, 2006
Primary chronic cold agglutinin disease: a population based clinical study of 86 patientsSigbjørn Berentsen, Elling Ulvestad, Ruth Langholm, et al.
Oncogene|December 24, 2003
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cellsTorstein Baade Ro, Randi Utne Holt, Anne-Tove Brenne, et al.
Pageof 6